Resources Top 5: Mount Ridley sprints ahead in the gallium race, surging 140pc
Atlassian defends climate warrior CEO’s private jet bill
Health Check: CSL shares tumble after recovery proves to be a false dawn
Precision Points: Investors need to pay attention when a company makes this key announcement
Lunch Wrap: ASX slides on CSL’s shock guidance cut and WiseTech raid
Top 10 at 11: Healthcare and tech lead ASX lower as CSL and WiseTech bleed
Dr Boreham’s Crucible: Bcal scores a diagnostic hat-trick with new cancer blood tests
Beyond the Degrussa Era: Why ASX explorers believe the Bryah Basin’s best days lie ahead
‘Just do it again’: Nike launches ‘anti-gravity’ shoe tech to reclaim market edge
How Black Rock Mining’s graphite strategy is sliding into place at Mahenge
Contributors
Our Resident Experts
Mining
Beyond the Degrussa Era: Why ASX explorers believe the Bryah Basin’s best days lie ahead
How Black Rock Mining’s graphite strategy is sliding into place at Mahenge
Resources Top 5: Cazaly cops speeding ticket as gold, silver and rare earths keep on truckin’
Kristie Batten: Fortescue-backed Magmatic making moves in two major gold fields
Barry FitzGerald: With Torque’s market valuation, small cap punters may pull off their own Paris gold heist
Featured in Mining
Tech
Three ways to manage risk when investing in real estate private credit
Stealing from the Louvre? In this economy, go for it
Ovanti targets major fintech deals at Money20/20 conference in Las Vegas
Fear and distrust are hampering Victoria’s tech future: KordaMentha report
How X2M Connect became the quiet Australian powering Asia’s smart utilities
Featured in Tech
Health & Biotech
Dr Boreham’s Crucible: Bcal scores a diagnostic hat-trick with new cancer blood tests
Health Check: Cashed-up clinical-stage biotechs are poised to go all the way
Deals, data and diagnoses: healthcare stocks stay active despite a softer week
ASX Quarterly Health Wrap: Lumos lands US$317m deal as ReNerve and Vitrafy hit key milestones
Vital Signs Podcast: Redefining hearing health
Featured in Health & Biotech
Experts
Stock Tips: Analysts turn to safe hands and travel plans in rough seas
The superannuation hotspots with the highest average balances
The three fears stalking investors right now – but why calm heads will prevail
Big super’s unprecedented bets in Trump’s America face rising risks
Criterion: Look beyond this year’s AGM theatrics to the underlying earnings messages
Too big to invest: $4.3 trillion super savings outgrow Australia
A $200k super blunder: here’s what not to do with your nest egg
